Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New clinical data presented on anticancer agents GSK-2118436 and GSK-1120212

Oct. 28, 2010

MolMed begins enrollment in phase II trial of NGR-hTNF in soft tissue sarcomas

Oct. 27, 2010

New inhibitors of dual specificity protein kinase TTK presented

Oct. 27, 2010

BMS-690514 shows potential to treat non-small cell lung cancer

Oct. 27, 2010

CHMP recommends new indication for Bristol-Myers Squibb's Sprycel

Oct. 26, 2010

CHMP recommends variation of marketing authorization for Pfizer's Sutent

Oct. 26, 2010

Merck KGaA presents new E-NPP 2 inhibitors

Oct. 26, 2010

Linifanib monotherapy is active in phase II NSCLC trial

Oct. 26, 2010

Trastuzumab approved by FDA for HER2-positive metastatic stomach cancer

Oct. 25, 2010

Phase III trial of clofarabine/cytarabine combination in leukemia meets secondary endpoints

Oct. 25, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...